CXCR2 and neoplasm: CXCR2 is of particular interest because its primary ligand CXCL8 exerts strong pro-tumor effects through recruitment of myeloid derived suppressor cells (MDSCs) [45], enhancement of angiogenesis [46] and increased tumor metastases [44, 47].